RE: better choice for many
We must remember this is a single dose vaccine versus two doses for Pfizer, BioNTech vaccine and the Moderna vaccine.
I think the Pfizer vaccine after the first dose is achieved maybe a 52% efficacy or something like that. Johnson & Johnson’s results are significantly better than what we’ve seen from the single-dose of Pfizer.
I think that’s the thing to keep in mind that a single dose vaccine, there’s definitely some advantages and this isn’t necessarily bad efficacy at all for one dose.
The FDA has always said 50% is enough to get emergency use authorization. Certainly anything above 50%, anything above in the 66% range, especially in the U.S. it’s 72 if we don’t start having variants, I think it’s pretty good and certainly going to help reduce the spread. As you’re reducing the spread then that ultimately will help us get rid of the virus.
Also, they are testing to see if a second dose increases the effectiveness, so after June 30th, if they have determined it does, they could always circle back and vaccinate everybody a second time.